Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martina Bedeschi
Observed names:
Bedeschi, Martina,
M. Bedeschi
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
University of Nottingham,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
University of Bologna
ORCID:
0000-0002-3678-3372
Observed ORCID:
0000-0002-3678-3372
OpenAlex ID:
A5080432668
Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance
2023
·
Martina Bedeschi
, Noemi Marino
, et al.
·
Cells
·
63
PDF
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents
2023
·
Pasquale Linciano
, Claudia Sorbi
, et al.
·
European Journal of Medicinal Chemistry
·
27
PDF
Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic properties
2023
·
Filippo Basagni
, Jose A. Ortega
, et al.
·
European Journal of Medicinal Chemistry
·
22
PDF
The Spheroid Light Microscopy Image Atlas for morphometrical analysis of three-dimensional cell cultures
2025
·
Eva Blondeel
, Arne Peirsman
, et al.
·
Scientific Data
·
19
PDF
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors
2023
·
Elisabetta Lazzarini
, Domenico Alessandro Silvestris
, et al.
·
Journal of Neuro-Oncology
·
12
Glitches in the brain: the dangerous relationship between radiotherapy and brain fog
2024
·
Noemi Marino
, Martina Bedeschi
, et al.
·
Frontiers in Cellular Neuroscience
·
9
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain
2023
·
Giacomo Rossino
, Annamaria Marra
, et al.
·
Pharmaceuticals
·
9
PDF
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer
2022
·
Anna Tesei
, Michela Cortesi
, et al.
·
Molecules
·
7
PDF
Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies
2025
·
Martina Bedeschi
, Elena Cavassi
, et al.
·
Pharmaceuticals
·
5
Redefine tumor spheroids heterogeneity via PCA-coupled biophysical characterization
2025
·
Domenico Andrea Cristaldi
, Martina Bedeschi
, et al.
·
Scientific Reports
·
2
PDF
Development of a 3D bioprinted human skin model for predictive toxicology
2026
·
Francesco Ganzerli
, Tiziana Petrachi
, et al.
·
Biomedicine & Pharmacotherapy
·
1
Sustainable chemistry and preclinical characterization of RC-106·HCl: A brain-penetrant pan sigma receptor modulator for glioblastoma
2026
·
Noemi Marino
, Roberta Listro
, et al.
·
European Journal of Pharmaceutical Sciences
·
1
Preparation of a Micronutrient-Enriched Apricot Kernel Oil and Assessment of In Vitro Chemopreventive Properties
2025
·
Melania Elettra Vaccari
, Valeria Cavalloro
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
A step-by-step protocol based on data mining to explore purinergic signaling in glioblastoma
2025
·
Martina Bedeschi
, Ankita Agrawal
, et al.
·
Purinergic Signalling
·
1
Chemotherapy-induced immunogenic hub restores NK cell activity via P2X7R in NSCLC
2026
·
Martina Bedeschi
, Elena Cavassi
, et al.
·
Research Square
AMPK Pathway Activation Markers in GBM: Expression Patterns and Clinical Associations in a Real-World Study
2026
·
Federica Ferrarini
, Paola Del Bianco
, et al.
·
International Journal of Molecular Sciences
CDKN2A gene fusions in glioblastoma: validation and functional characterization
2026
·
Bedeschi, Martina
·
AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
PDF
pACC and pAMPK Immunohistochemical Quantification in Recurrent Glioblastoma treated with regorafenib or with fotemustine/lomustine — Digital Pathology Dataset
2026
·
Ferrarini, Federica
, Del Bianco, Paola
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385
2025
·
Martina Bedeschi
, Elena Cavassi
, et al.
·
Pharmaceuticals
PDF
253 (PB241): Targeting the HuR-RNA complexes as innovative strategy for glioblastoma treatment
2024
·
M. Bedeschi
, M.E. Vaccari
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
22
Citation count:
181
H-index:
7
I10-index:
5
Year
Topic
Type